References
- Abdelbary AA, Abd-Elsalam WH, Al-mahallawi AM. (2019). Fabrication of levofloxacin polyethylene glycol decorated nanoliposomes for enhanced management of acute otitis media: Statistical optimization, trans-tympanic permeation and in vivo evaluation. Int J Pharm 559:201–9.
- Abdelbary AA, AbouGhaly MHH. (2015). Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm 485:235–43.
- Abdelgawad R, Nasr M, Moftah NH, Hamza MY. (2017). Phospholipid membrane tubulation using ceramide doping “Cerosomes”: Characterization and clinical application in psoriasis treatment. Eur J Pharm Sci 101:258–68.
- Abdellatif MM, Khalil IA, Khalil MAF. (2017). Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: in-vitro, ex-vivo and in-vivo evaluation. Int J Pharm 527:1–11.
- Abd-Elsalam WH, El-Helaly SN, Ahmed MA, Al-Mahallawi AM. (2018). Preparation of novel phospholipid-based sonocomplexes for improved intestinal permeability of rosuvastatin: In vitro characterization, dynamic simulation, Caco-2 cell line permeation and in vivo assessment studies. Int J Pharm 548:375–84.
- Abd-Elsalam WH, El-Zahaby SA, Al-Mahallawi AM. (2018). Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery. Drug Deliv 25:484–92.
- Albash R, Abdelbary AA, Refai H, El-Nabarawi MA. (2019). Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation. Int J Nanomedicine 14:1953–68.
- Albash R, El-Nabarawi MA, Refai H, Abdelbary AA. (2019). Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment. Int J Nanomedicine 14:6555–74.
- Al-Mahallawi AM, Khowessah OM, Shoukri RA. (2014). Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm 472:304–14.
- Auría-Soro C, Nesma T, Juanes-Velasco P, et al. (2019). Interactions of nanoparticles and biosystems: microenvironment of nanoparticles and biomolecules in nanomedicine. Nanomaterials 9:1365.
- Bnyan R, Khan I, Ehtezazi T, et al. (2018). Surfactant effects on lipid-based vesicles properties. J Pharm Sci 107:1237–46.
- Caliceti P, Salmaso S, Elvassore N, Bertucco A. (2004). Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques. J Control Release 94:195–205.
- Campos R, Bittencourt SF, Rojas-Moscoso JA, et al. (2018). The rabbit vagina as an in vivo model for vaginal fenticonazole permeability and toxicity. J Pharmacol Toxicol Methods 94:14–8.
- Castro BM, Prieto M, Silva LC. (2014). Ceramide: a simple sphingolipid with unique biophysical properties. Prog Lipid Res 54:53–67.
- Fang J-Y, Leu Y-L, Chang C-C, et al. (2004). Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery. Drug Deliv 11:97–105.
- Farrah AY, Al-mahallawi AM, Basalious EB, Nesseem DI. (2020). Investigating the potential of phosphatidylcholine-based nano-sized carriers in boosting the oto-topical delivery of caroverine: in vitro characterization, stability assessment and ex vivo transport studies. Int J Nanomedicine 15:8921–31.
- Hu Y, Xie J, Tong YW, Wang C-H. (2007). Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release 118:7–17.
- Jennemann R, Rabionet M, Gorgas K, et al. (2012). Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum Mol Genet 21:586–608.
- Jung E, Bisco A, Azzollini E, et al. (1988). Fenticonazole cream once daily in dermatomycosis, a double-blind controlled trial versus bifonazole. Dermatologica 177:104–8.
- Khazanov E, Priev A, Shillemans JP, Barenholz Y. (2008). Physicochemical and biological characterization of ceramide-containing liposomes: paving the way to ceramide therapeutic application. Langmuir 24:6965–80.
- Meckfessel MH, Brandt S. (2014). The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products. J Am Acad Dermatol 71:177–84.
- Moolakkadath T, Aqil M, Ahad A, et al. (2018). Development of transethosomes formulation for dermal fisetin delivery: Box-Behnken design, optimization, in vitro skin penetration, vesicles-skin interaction and dermatokinetic studies. Artif Cells Nanomed Biotechnol 46:755–65.
- Quaglia MG, Donati E, Bossù E, et al. (2001). Determination of fenticonazole and its impurities by capillary electrophoresis and high performance liquid chromatography. J Sep Science 24:392–6.
- Radwan SAA, El-Maadawy WH, Yousry C, et al. (2020). Zein/phospholipid composite nanoparticles for successful delivery of gallic acid into ahscs: Influence of size, surface charge, and vitamin a coupling. Int J Nanomedicine 15:7995–8018.
- Rangsimawong W, Opanasopit P, Rojanarata T, Ngawhirunpat T. (2014). Terpene-containing PEGylated liposomes as transdermal carriers of a hydrophilic compound. Biol Pharm Bull 37:1936–43.
- Roberts MS, Mohammed Y, Pastore M, et al. (2017). Topical and cutaneous delivery using nanosystems. J Control Release 247:86–105..
- Stetefeld J, McKenna SA, Patel TR. (2016). Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys Rev 8:409–27.
- Su R, Yang L, Wang Y, et al. (2017). Formulation, development, and optimization of a novel octyldodecanol-based nanoemulsion for transdermal delivery of ceramide IIIB. Int J Nanomedicine 12:5203–21.
- Tagami T, Ernsting MJ, Li S-D. (2011). Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. J Control Release 154:290–7.
- Varona S, Martín Á, Cocero MJ, (2011). Liposomal incorporation of lavandin essential oil by a thin-film hydration method and by particles from gas-saturated solutions. Ind Eng Chem Res 50:2088–97.
- Vega E, Egea MA, Garduño-Ramírez ML, et al. (2013). Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy. Colloids Surf B Biointerfaces 110:339–46.
- Veraldi S, Milani R. (2008). Topical fenticonazole in dermatology and gynaecology: Current role in therapy. Drugs 68:2183–94.
- Yilmaz E, Borchert H-H. (2005). Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides. Eur J Pharm Biopharm 60:91–8.
- Yousry C, Ahmed IS, Amin MM, Gazayerly ONE. (2019). Superhydrophobic substrates for ultrahigh encapsulation of hydrophilic drug into controlled- release polyelectrolyte complex beads: statistical optimization and in vivo evaluation. Pharmaceutics 11:257.
- Yousry C, Elkheshen SA, El-laithy HM, et al. (2017). Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery. Eur J Pharm Sci 100:142–54.
- Yousry C, Fahmy RH, Essam T, et al. (2016). Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation. Drug Dev Ind Pharm 42:1752–62.
- Yousry C, Zikry PM, Basalious EB, et al. (2020). Self-nanoemulsifying system optimization for higher terconazole solubilization and non-irritant ocular administration. Adv Pharm Bull 10:389–98.
- Yousry C, Zikry PM, Salem HM, et al. (2020). Integrated nanovesicular/self-nanoemulsifying system (INV/SNES) for enhanced dual ocular drug delivery: statistical optimization, in vitro and in vivo evaluation. Drug Deliv Transl Res 10:801–14.
- Zeb A, Qureshi OS, Kim H-S, et al. (2016). Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomedicine 11:3813–24.